P
Peter Paul M. Willemse
Researcher at Utrecht University
Publications - 5
Citations - 586
Peter Paul M. Willemse is an academic researcher from Utrecht University. The author has contributed to research in topics: Prostate cancer & Biochemical recurrence. The author has an hindex of 5, co-authored 5 publications receiving 277 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
Thomas Van den Broeck,Roderick C.N. van den Bergh,Nicolas Arfi,Tobias Gross,Lisa Moris,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Maria De Santis,Derya Tilki,Stefano Fanti,Nicola Fossati,Silke Gillessen,Silke Gillessen,Silke Gillessen,Jeremy Grummet,Ann Henry,Michael Lardas,Matthew Liew,Olivier Rouvière,Jakub Pecanka,Malcolm David Mason,Ivo G. Schoots,Theo H. van der Kwast,Henk G. van der Poel,Thomas Wiegel,Peter Paul M. Willemse,Yuhong Yuan,Thomas B. Lam,Thomas B. Lam,Philip Cornford,Nicolas Mottet +31 more
TL;DR: BCR has an impact on survival, but this effect appears to be limited to a subgroup of patients with specific clinical risk factors, which may form the basis of new BCR risk stratification (European Association of Urology BCR Risk Groups), which needs to be validated formally.
Journal ArticleDOI
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
Thomas B. Lam,Thomas B. Lam,Steven MacLennan,Peter Paul M. Willemse,Malcolm David Mason,Karin Plass,Robert Shepherd,Ruud Baanders,Chris H. Bangma,Anders Bjartell,Alberto Bossi,Erik Briers,Alberto Briganti,Karel Tim Buddingh,James W.F. Catto,James W.F. Catto,Maurizio Colecchia,Brett Cox,Marcus G. Cumberbatch,Jeff Davies,Niall F. Davis,Maria De Santis,Paolo Dell'Oglio,André Deschamps,James Donaldson,James Donaldson,Shin Egawa,Christian D. Fankhauser,Stefano Fanti,Nicola Fossati,Giorgio Gandaglia,Silke Gillessen,Silke Gillessen,Nikolaos Grivas,Tobias Gross,Jeremy Grummet,Ann Henry,Alexandre Ingels,Jacques Irani,Michael Lardas,Matthew Liew,Daniel W. Lin,Daniel W. Lin,Lisa Moris,Muhammad Imran Omar,Karl H. Pang,Catherine Paterson,Catherine Paterson,Catherine Paterson,Raphaële Renard-Penna,Maria J. Ribal,Monique J. Roobol,Morgan Rouprêt,Olivier Rouvière,Gemma Sancho Pardo,Jonathan Richenberg,Ivo G. Schoots,J.P. Michiel Sedelaar,Phillip D. Stricker,Derya Tilki,Susanne Vahr Lauridsen,Roderick C.N. van den Bergh,Thomas Van den Broeck,Theodorus H. van der Kwast,Henk G. van der Poel,Geert J.L.H. van Leenders,Murali Varma,Philippe D. Violette,Christopher J.D. Wallis,Christopher J.D. Wallis,Thomas Wiegel,Karen Wilkinson,Fabio Zattoni,James N'Dow,James N'Dow,Hendrik Van Poppel,Philip Cornford,Nicolas Mottet +77 more
TL;DR: Consensus statements and the findings are expected to guide and inform routine clinical practice and research, until higher levels of evidence emerge through prospective comparative studies and clinical trials.
Journal ArticleDOI
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations.
Thomas Van den Broeck,Roderick C.N. van den Bergh,Erik Briers,Philip Cornford,Marcus G. Cumberbatch,Derya Tilki,Maria De Santis,Stefano Fanti,Nicola Fossati,Silke Gillessen,Jeremy Grummet,Ann Henry,Michael Lardas,Matthew Liew,Malcolm David Mason,Lisa Moris,Ivo G. Schoots,Theodorus H. van der Kwast,Henk G. van der Poel,Thomas Wiegel,Peter Paul M. Willemse,Olivier Rouvière,Thomas B. Lam,Nicolas Mottet +23 more
TL;DR: A novel BCR risk stratification system based on disease and prostate-specific antigen characteristics is developed for predicting which patients might progress to optimize treatment decisions.
Journal ArticleDOI
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Lisa Moris,Marcus G. Cumberbatch,Thomas Van den Broeck,Giorgio Gandaglia,Nicola Fossati,Brian D. Kelly,Raj P. Pal,Erik Briers,Philip Cornford,Maria De Santis,Stefano Fanti,Silke Gillessen,Silke Gillessen,Jeremy Grummet,Ann Henry,Thomas B. Lam,Thomas B. Lam,Michael Lardas,Matthew Liew,Malcolm David Mason,Muhammad Imran Omar,Olivier Rouvière,Ivo G. Schoots,Derya Tilki,Roderick C.N. van den Bergh,Theodorus H. van der Kwast,Henk G. van der Poel,Peter Paul M. Willemse,Cathy Yuhong Yuan,Badrinath R. Konety,Tanya B. Dorff,Tanya B. Dorff,Suneil Jain,Suneil Jain,Nicolas Mottet,Thomas Wiegel +35 more
TL;DR: A systematic review of the existing literature on the effectiveness of the different primary treatment modalities for high-risk localized and locally advanced prostate cancer concluded that both RP as part of multimodal treatment and EBRT’+ long-term ADT can be recommended as primary treatment in high- risk and locallyAdvanced PCa.
Journal ArticleDOI
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].
J. Alfred Witjes,Marek Babjuk,Marek Babjuk,Joaquim Bellmunt,Joaquim Bellmunt,H. Maxim Bruins,Theo M. de Reijke,Maria De Santis,Maria De Santis,Silke Gillessen,Nicholas D. James,Nicholas D. James,Steven MacLennan,Juan Palou,Thomas Powles,Maria J. Ribal,Shahrokh F. Shariat,Theo H. van der Kwast,Evanguelos Xylinas,Neeraj Agarwal,Tom J.H. Arends,Aristotle Bamias,Alison Birtle,Peter C. Black,Bernard H. Bochner,Bernard H. Bochner,Michel Bolla,Joost L. Boormans,Alberto Bossi,Alberto Briganti,Iris Brummelhuis,Max Bürger,Daniel Castellano,Richard Cathomas,Arturo Chiti,Ananya Choudhury,Eva Compérat,Simon J. Crabb,Stéphane Culine,Berardino De Bari,Berardino De Bari,Willem de Blok,Pieter De Visschere,Karel Decaestecker,Konstantinos Dimitropoulos,J. Domínguez-Escrig,Stefano Fanti,Valérie Fonteyne,Mark Frydenberg,Jurgen J. Fütterer,Georgios Gakis,Bogdan Geavlete,Paolo Gontero,Bernhard Grubmüller,Shaista Hafeez,Donna E. Hansel,Arndt Hartmann,Dickon Hayne,Ann Henry,Virginia Hernández,Harry W. Herr,Ken Herrmann,Peter Hoskin,Jorge Huguet,Barbara Alicja Jereczek-Fossa,Robert Jones,Ashish M. Kamat,Vincent Khoo,Anne E. Kiltie,Susanne Krege,Sylvain Ladoire,Pedro C. Lara,Annemarie Leliveld,Estefania Linares-Espinós,Vibeke Løgager,Anja Lorch,Yohann Loriot,Richard P. Meijer,M. Carmen Mir,Marco Moschini,Hugh Mostafid,A. Müller,Christoph R. Müller,James N'Dow,James N'Dow,Andrea Necchi,Yann Neuzillet,Jorg R. Oddens,Jan Oldenburg,Jan Oldenburg,Susanne Osanto,Wim J.G. Oyen,Luís Pacheco-Figueiredo,Helle Pappot,Manish I. Patel,Bradley R. Pieters,Karin Plass,Mesut Remzi,Margitta Retz,Jonathan Richenberg,Jonathan Richenberg,Michael Rink,Florian Roghmann,Jonathan E. Rosenberg,Jonathan E. Rosenberg,Morgan Rouprêt,Olivier Rouvière,Carl Salembier,Antti Salminen,Paul Sargos,Shomik Sengupta,Shomik Sengupta,Amir Sherif,Robert Jan Smeenk,Anita Smits,Arnulf Stenzl,George N. Thalmann,Bertrand Tombal,Baris Turkbey,Susanne Vahr Lauridsen,Riccardo Valdagni,Antoine G. van der Heijden,Hein Van Poppel,Mihai Dorin Vartolomei,Mihai Dorin Vartolomei,Erik Veskimäe,Antoni Vilaseca,Franklin A. Vives Rivera,Thomas Wiegel,Peter Wiklund,Peter Wiklund,Peter Paul M. Willemse,Andrew K. Williams,Richard Zigeuner,Alan Horwich +134 more
TL;DR: The authors regret that a co-author was mistakenly missed from the authorship.